These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15578351)

  • 1. A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.
    Crum NF; Groff HL; Parrish JS; Ring W
    Clin Infect Dis; 2004 Dec; 39(11):e122-3. PubMed ID: 15578351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drotrecogin alpha (activated) in septic shock after lung transplant.
    Feltracco P; Rea F; Ori C
    J Heart Lung Transplant; 2008 Jul; 27(7):815. PubMed ID: 18582817
    [No Abstract]   [Full Text] [Related]  

  • 3. Drotrecogin alpha (activated) in neonatal septic shock.
    Frommhold D; Birle A; Linderkamp O; Zilow E; Pöschl J
    Scand J Infect Dis; 2005; 37(4):306-8. PubMed ID: 15804668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure.
    Albuali WH; Singh RN; Fraser DD; Scott LA; Kornecki A
    Saudi Med J; 2005 Aug; 26(8):1289-92. PubMed ID: 16127532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of activated protein C in a case of paediatric septic shock.
    Verre M; Barozzi E; Piccirillo M; Tancioni F; Tiburzi S; Varano M
    Minerva Pediatr; 2005 Dec; 57(6):429-32. PubMed ID: 16402015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drotrecogin alfa (activated) in septic shock.
    Nayyar V; Solano T
    N Engl J Med; 2012 Sep; 367(10):968-9; author reply 969. PubMed ID: 22931268
    [No Abstract]   [Full Text] [Related]  

  • 8. Drotrecogin alfa (activated) in septic shock.
    Hollander JE
    N Engl J Med; 2012 Sep; 367(10):968; author reply 969. PubMed ID: 22931267
    [No Abstract]   [Full Text] [Related]  

  • 9. Drotrecogin alfa (activated) for nonmenstrual toxic shock syndrome associated with methicillin resistant Staphylococcus aureus infection.
    Haddadin DW; Samnani IQ; Moorman JP
    South Med J; 2006 Nov; 99(11):1295-6. PubMed ID: 17195430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.
    Bachli EB; Vavricka SR; Walter RB; Leschinger MI; Maggiorini M
    Intensive Care Med; 2003 Feb; 29(2):337. PubMed ID: 12594601
    [No Abstract]   [Full Text] [Related]  

  • 11. Drotrecogin alfa (activated) in an infant with gram-negative septic shock.
    Sajan I; Da-Silva SS; Dellinger RP
    J Intensive Care Med; 2004; 19(1):51-5. PubMed ID: 15035755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
    Huston JM; Eachempati SR; Rodney JR; Cayci C; Fusco D; Mathew M; Shou J; Goldstein MJ; Kapur S; Barie PS
    Transpl Infect Dis; 2009 Jun; 11(3):277-80. PubMed ID: 19392733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of septic shock and use of drotrecogin alfa (activated) in children.
    Marraro GA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):769-72. PubMed ID: 19735218
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated recombinant protein C in septic shock early after liver transplantation: a case report.
    Feltracco P; Bortolato A; Rizzi S; Barbieri S; Furnari M; Serra E; Milevoj M; Ori C
    Transplant Proc; 2008; 40(6):2070-2. PubMed ID: 18675133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature.
    Funk DJ; Palma Vargas J; Tuttle-Newhall J; Moretti EW
    Transpl Infect Dis; 2011 Dec; 13(6):592-7. PubMed ID: 21794040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock.
    Rice TW; Bernard GR
    Am J Med Sci; 2004 Oct; 328(4):205-14. PubMed ID: 15486535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On activated protein C in septic shock].
    Offenstadt G
    Presse Med; 2006 Jun; 35(6 Pt 1):989; author reply 989. PubMed ID: 16783262
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients.
    Bilbault P; Lavaux T; Launoy A; Gaub MP; Meyer N; Oudet P; Pottecher T; Jaeger A; Schneider F
    Crit Care Med; 2007 Jan; 35(1):69-75. PubMed ID: 17133181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
    Annane D; Timsit JF; Megarbane B; Martin C; Misset B; Mourvillier B; Siami S; Chagnon JL; Constantin JM; Petitpas F; Souweine B; Amathieu R; Forceville X; Charpentier C; Tesnière A; Chastre J; Bohe J; Colin G; Cariou A; Renault A; Brun-Buisson C; Bellissant E;
    Am J Respir Crit Care Med; 2013 May; 187(10):1091-7. PubMed ID: 23525934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
    Barie PS; Hydo LJ; Shou J; Eachempati SR
    Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.